Human T cells with a type-2 cytokine profile are resistant to apoptosis induced by primary activation: Consequences for immunopathogenesis

Clinical and Experimental Immunology

Volumn 120, Issue 3, 2000, Pages 454-462

  Carbonari, M ^a   Tedesco, T ^a   Del Porto, P ^a   Paganelli, R ^a   Fiorilli, M ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

AIDS; Apoptosis; Cytokines; Eosinophilia; Tht Th2

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 4; IONOMYCIN; PHORBOL ESTER;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; APOPTOSIS; ARTICLE; CELL VIABILITY; CHURG STRAUSS SYNDROME; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPEREOSINOPHILIA; HYPEREOSINOPHILIC SYNDROME; IMMUNOFLUORESCENCE; IMMUNOPATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIGENS, CD4; ANTIGENS, CD8; APOPTOSIS; CELLS, CULTURED; EOSINOPHILIA; HUMANS; HYPERGAMMAGLOBULINEMIA; IMMUNE SYSTEM DISEASES; IMMUNOGLOBULIN E; INTERFERON TYPE II; INTERLEUKIN-4; PROTO-ONCOGENE PROTEINS C-BCL-2; T-LYMPHOCYTES;

EID: 0034042715     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2000.01243.x     Document Type: Article

References (42)

1. 1 Mosmann TR, Subash S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996; 17:138-46.
2. 2 Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996; 383:787-93.
3. 3 Romagnani S. Th1 and Th2 in human diseases. Clin Immunol Immunopathol 1996; 80:225-32.
4. 4 Paganelli R, Scala E, Ansotegui IJ et al. CD8+ T lymphocytes provide helper activity for IgE synthesis in HIV-infected patients with hyperIgE. J Exp Med 1995; 181:423-8.
5. 5 Maggi E, Giudizi MG, Biagiotti R et al. Th2-like CD8+ T cells showing B cell helper function and reduced cytolytic activity in human immunodeficiency virus type 1 infection. J Exp Med 1994; 180:489-92.
6. 6 Peritt D, Robertson S, Gri G, Showe L, Aste-Amezaga M, Trinchieri G. Differentiation of human NK cells into NK1 and NK2 subsets. J Immunol 1998; 161:5821-4.
7. + T cells in a Th2 response and in immunoglobulin E production. Science 1995; 270:1845-7.
8. 8 Cogan E, Schandené L, Crusiaux A, Cochaux P, Velu T, Goldman M. Clonal proliferation of type 2 helper T cells in a man with the hypereosinophilic syndrome. N Engl J Med 1994; 330:535-8.
9. -3CD4+ T-cell population able to secrete large amounts of interleukin-5. Blood 1996; 87:1416-22.
10. + effector T cells transiently expressing the natural killer cell marker CD57/HNK1. Immunology 1997; 91:541-7.
11. 11 Umetsu DT, DeKruyff RH. Th1 and Th2 CD4+ cells in human allergic diseases. J Allergy Clin Immunol 1997; 100:1-6.
12. 12 Chilosi M, Facchetti F, Notarangelo LD et al. CD30 cell expression and abnormal soluble CD30 serum accumulation in Omenn's syndrome: evidence for a T helper 2-mediated condition. Eur J Immunol 1996; 26:329-34.
13. 13 Clerici M, Shearer GM. A Th1-Th2 switch is a critical step in the etiology of HIV infection. Immunol Today 1993; 14:107-11.
14. 14 Graziosi C, Pantaleo G, Gnatt KR et al. Lack of evidence for the dichotomy of Th1 and Th2 predominance in HIV-infected individuals. Science 1994; 265:248-51.
15. 15 Maggi E, Mazzetti M, Ravina A et al. Ability of HIV to promote a Th1 to Th0 shift and to replicate preferentially in Th2 and Th0 cells. Science 1994; 265:244-6.
16. 16 Meyaard L, Hovenkamp E, Keet IP et al. Single-cell analysis of IL-4 and IFN-γ production by T cells from HIV-infected individuals: decreased IFN-γ in the presence of preserved IL-4 production. J Immunol 1996; 157:2712-8.
17. 17 Klein SA, Dobmeyer JM, Dobmeyer TS et al. Demonstration of the Th1 to Th2 cytokine shift during the course of HIV-1 infection using cytoplasmic cytokine detection on single cell level by flow cytometry. AIDS 1997; 11:1111-8.
18. 18 Constant SL, Bottomly K. Induction of Th1 and Th2, CD4+ T cell responses: the alternative approaches. Annu Rev Immunol 1997; 15:297-322.
19. 19 Murray JS. How the MHC selects Th1/Th2 immunity. Immunol Today 1998; 19:157-62.
20. 20 Murphy KM. T lymphocyte differentiation in the periphery. Curr Opin Immunol 1998; 10:226-32.
21. 21 Ramsdell F, Seaman MS, Miller RE, Picha KS, Kennedy MK, Lynch DH. Differential ability of Th1 and Th2 T cells to express Fas ligand and to undergo activation-induced cell death. Int Immunol 1994; 6:1545-53.
22. 22 Oberg HH, Lengl-Jangben B, Kabelitz D, Janssen O. Activation-induced T cell death: resistance or susceptibility correlate with cell surface Fas ligand expression and T helper phenotype. Cell Immunol 1997; 181:93-100.
23. 23 Accornero P, Raddrizzani M, Delia D, Gerosa F, Kurrle R, Colombo MP. Differential susceptibility to HIV-gp120-sensitized apoptosis in CD4+ T-cell clones with different T-helper phenotypes: role of CD95/ CD95L interactions. Blood 1997; 89:558-69.
24. 24 Varadhachary AS, Perdow SN, Hu C, Ramanarayanan M, Salgame P. Differential ability of T cell subsets to undergo activation-induced cell death. Proc Natl Acad Sci USA 1997; 94:5778-83.
25. 25 Zhang X, Brunner T, Carter L et al. Unequal death in T helper cell (Th)1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/ FasL-mediated apoptosis. J Exp Med 1997; 185:1837-49.
26. + T cells are resistant to glucocorticoid-induced apoptosis: implications for the Th1/Th2 balance. J Immunol 1998; 161:1239-47.
27. 27 Watanabe N, Arase H, Kurasawa K et al. Th1 and Th2 subsets equally undergo Fas-dependent and -independent activation-induced cell death. Eur J Immunol 1997; 27:1858-64.
28. 28 Jennette JC, Falk RJ, Andrassy K et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994; 37:187-92.
29. 29 Picker LJ, Singh MK, Zdraveski Z et al. Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry. Blood 1995; 86:1408-19.
30. 30 Scala E, Carbonari M, Del Porto P et al. LAG-3 expression and IFN-γ production are variably coregulated in human T lymphocyte subpopulations. J Immunol 1998; 161:489-93.
31. 31 Carbonari M, Cibati M, Chercha M et al. Detection and characterization of apoptotic peripheral blood lymphocytes in HIV infection and cancer chemotherapy by a novel flow immunocytometric method. Blood 1994; 83:1268-77.
32. 32 Carbonari M, Pesce AM, Cibati M et al. Death of bystander cells by a novel pathway involving early mitochondrial damage in HIV-related lymphadenopathy. Blood 1997; 90:209-16.
33. 33 Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119:493-501.
34. 34 Davodeau F, Peyrat M-A, Necker A et al. Close phenotypic and functional similarities between human and murine αβ T cells expressing invariant TCR α-chains. J Immunol 1997; 158:5603-11.
35. 35 Legac E, Autran B, Merle-Beral H, Katlama C, Debre P. CD4+CD7-CD57+ T cells: a new T-lymphocyte subset expanded during human immunodeficiency virus infection. Blood 1992; 79:1746-52.
36. 36 Gougeon ML, Lecoeur H, Dulioust A et al. Programmed cell death in peripheral lymphocytes from HIV-infected persons: increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression. J Immunol 1996; 156:3509-20.
37. 37 Ledru E, Lecoeur H, Garcia S, Debord T, Gougeon ML. Differential susceptibility to activation-induced apoptosis among peripheral Th1 subsets: correlation with Bcl-2 expression and consequences for AIDS pathogenesis. J Immunol 1998; 160:3194-206.
38. 38 Pearson CI, van Ewijk W, McDevitt HO. Induction of apoptosis and T helper 2 (Th2) responses correlates with peptide affinity for the major histocompatibility complex in self-reactive T cell receptor transgenic mice. J Exp Med 1997; 185:583-99.
39. 39 Bretscher PA, Wei G, Menon JN, Bielefeldt-Ohmann H. Establishment of stable, cell mediated immunity that makes 'susceptible' mice resistant to Leishmania major. Science 1992; 257:359-42.
40. 40 Hosken N, Shibuya K, Heath AW, Murphy KM, O'Garra A. The effect of antigen dose on CD4+ T helper cell phenotype development in a T cell receptor-αβ-transgenic model. J Exp Med 1995; 182:1579-84.
41. 41 Sarzotti M, Robbins DS, Hoffman PM. Induction of protective CTL responses in newborn mice by a murine retrovirus. Science 1996; 271:1726-8.
42. 42 Croft M, Swain SL. Recently activated naive CD4 T cells can help resting B cells, and can produce sufficient autocrine IL-4 to drive differentiation to secretion of T helper 2-type cytokines. J Immunol 1995; 154:4269-82.